Recent research suggests that protective antibodies from Covid-19 vaccines, specifically the mRNA type, tend to decline ...

The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

Medicare Part B covers molecular, antigen, and antibody coronavirus testing from Medicare-approved labs. Medicare does not cover over-the-counter home test kits. Various tests can detect COVID-19 ...

Discover groundbreaking research from Emory University that has revealed that autoantibodies found in the nasal cavity may ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.

It’s cold and flu season and most of us will encounter a virus at some point. So, how does our immune system work to keep us ...

A study published in the journal Frontiers of Medicine has found an association between the inactivated COVID-19 vaccine CoronaVac from Sinovac ... normal values for ADAMTS13 antigen and inhibitory ...